Onvansertib in Combination with Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants with Metastatic Pancreatic Ductal Adenocarcinoma

Inova Schar Cancer Institute, Fairfax

Mayo Clinic Jacksonville, Jacksonville

Mayo Clinic Rochester, Rochester

University of Kansas Medical Center, Westwood

University of Nebraska Medical Center, Omaha

Mayo Clinic Phoenix, Phoenix